“FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS” (2026) Eureka Journal of Health Sciences & Medical Innovation, 2(6), pp. 1–11. Available at: https://eurekaoa.com/index.php/5/article/view/1148 (Accessed: 16 June 2026).